Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 3023 (LINC03023) is a human RNA gene classified as a long non-coding RNA (lncRNA). LncRNAs are transcripts longer than 200 nucleotides that do not encode functional proteins and typically exert regulatory roles at the transcriptional and epigenetic level. The specific biological function and pathological roles of LINC03023 remain uncharacterized in the published literature. It is part of the lincRNA family, indicating its transcript originates from a region of the genome that does not overlap protein-coding genes and may function in modulation of gene expression, chromatin architecture, or other aspects of cellular regulation in a context-dependent manner. There is currently no evidence that LINC03023 acts as a therapeutic target or biomarker, nor are there known interactions with drugs or established mechanisms of action related to pharmacology.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 3023 (LINC03023).